Skip to main content
OpenTrials

Clinical trial condition

Heredodegenerative Disorders, Nervous System

Explore clinical trials studying Heredodegenerative Disorders, Nervous System. Study availability and eligibility vary by location and protocol.

1,879 public trials 409 recruiting studies
Refine in advanced search Browse all conditions

Heredodegenerative Disorders, Nervous System trial results

Completed

REALITY LHON Registry

NCT03295071

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Eye Diseases, +13 more
Locations
  • Doheny Eye Center UCLA Pasadena Pasadena, California, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • Massachusetts Eye and Ear Infirmary Boston, Massachusetts, United States
  • Wills Eye Institute Philadelphia, Pennsylvania, United States
View Trial Details
Completed

RESCUE and REVERSE Long-term Follow-up

NCT03406104

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Eye Diseases, +13 more
Locations
  • Doheny Eye Center UCLA Pasadena, California, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • Wills Eye Institute Philadelphia, Pennsylvania, United States
  • CHNO Les Quinze Vingts Paris, France
View Trial Details
Completed

Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation (REVERSE)

NCT02652780

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Eye Diseases, +13 more
Locations
  • Doheny Eye Center, University of California, Los Angeles Los Angeles, California, United States
  • Department of Ophthalmology, Emory University School of Medicine Atlanta, Georgia, United States
  • Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • Centre National Hospitalier d'Ophtalmologie des Quinze-Vingt Paris, France
View Trial Details
Completed

Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation

NCT02652767

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Eye Diseases, +13 more
Locations
  • Doheny Eye Center, University of California, Los Angeles Los Angeles, California, United States
  • Department of Ophthalmology, Emory University School of Medicine Atlanta, Georgia, United States
  • Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • Centre National Hospitalier d'Ophtalmologie des Quinze-VingtCentre National Hospitalier d'Ophtalmologie des Quinze-Vingt Paris, France
View Trial Details
Completed

Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis

NCT05557162

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +13 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Mayo Clinic Health System - Eau Claire Eau Claire, Wisconsin, United States
View Trial Details
Completed

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

NCT05005845

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cutaneous Neurofibroma, Genetic Diseases, Inborn, +14 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Northwest Arkansas Clinical Trials Center, PLLC Rogers, Arkansas, United States
  • Center for Dermatology Clinical Research, Inc. Fremont, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 23 locations
View Trial Details

Related conditions